Phase I study of radioimmunotherapy with an anti-CD20 murine radioimmunoconjugate (^<90>Y-ibritumomab tiuxetan) in relapsed or refractory indolent B-cell lymphoma
スポンサーリンク
概要
- 論文の詳細を見る
- 2005-12-10
著者
-
WATANABE Takashi
Hematology and Stem Cell Transplantation Divisions, National Cancer Center Hospital
-
KOBAYASHI Yukio
Hematology and Stem Cell Transplantation Divisions, National Cancer Center Hospital
-
TOBINAI Kensei
Hematology and Stem Cell Transplantation Divisions, National Cancer Center Hospital
-
NAKATA Masanobu
Division of Oncology and Hematology, National Cancer Center Hospital East
-
Tobinai K
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
Tobinai Kensei
国立がんセンター中央病院 血液内科グループ
-
Tobinai Kensei
東海大学 医学部
-
TSURUTA Kazuto
the Department of Laboratory Midicine
-
Nakamura Shigeo
群馬県立がんセンター 病理検査
-
Kishimoto Yuji
The First Department Of Internal Medicine Kansai Medical University
-
Kato T
Department Of Gastroenterological Surgery Aichi Cancer Center Hospital
-
Kagami Y
Department Of Hematology Japanese Red Cross Nagoya First Hospital
-
Takeuchi T
Cancer Screening Division Research Center For Cancer Prevention And Screening National Cancer Center
-
Takeuchi Takahiro
愛知県立がんセンター病院
-
Kobayashi Y
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
TERUI Shoji
Diagnostic Radiology Division, National Cancer Center Hospital
-
ITOH Kuniaki
Hematology and Oncology Division, National Cancer Center Hospital East
-
TERAUCHI Takashi
Diagnostic Division, Research Center for Cancer Prevention and Screening, National Cancer Center
-
IGARASHI Tadahiko
Hematology and Oncology Division, National Cancer Center Hospital East
-
USUBUCHI Noriko
Hematology and Oncology Division, National Cancer Center Hospital East
-
NAKATA Masanobu
Hematology and Oncology Division, National Cancer Center Hospital East
-
NAWANO Shigeru
Diagnostic Radiology Division, National Cancer Center Hospital East
-
SEKIGUCHI Naohiro
Hematology and Stem Cell Transplantation Division, National Cancer Center Hospital
-
KUSUMOTO Shigeru
Hematology and Stem Cell Transplantation Division, National Cancer Center Hospital
-
TANIMOTO Kazuki
Hematology and Stem Cell Transplantation Division, National Cancer Center Hospital
-
ENDO Keigo
Nuclear Medicine, Gunma University Hospital
-
SERIU Taku
Nuclear Medicine, Gunma University Hospital
-
HAYASHI Masaki
Nuclear Medicine, Gunma University Hospital
-
Usubuchi Noriko
国立がんセンター中央病院
-
Usubuchi Noriko
Hematology And Oncology Division National Cancer Center Hospital East
-
Togitani Kazuto
Hematology Division National Cancer Center Hospital
-
Takayama K
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Takeyama Kunihiko
東海大学 医学部
-
Sekiguchi N
National Cancer Center Hospital Tokyo Jpn
-
Sekiguchi Naohiro
国立がんセンター中央病院
-
Sekiguchi Naohiro
Hematology Division National Cancer Center Hospital
-
Kusumoto Shigeru
Division Of Hematology And Hematopoietic Stem Cell Transplantation National Cancer Center Hospital
-
Nakata M
Division Of Oncology And Hematology National Cancer Center Hospital East
-
Nakata Masanobu
東海大学 医学部血液･腫瘍内科
-
Seriu Taku
Nuclear Medicine Gunma University Hospital
-
Tanimoto Kazuki
国立がんセンター中央病院
-
Terauchi Takashi
国立がんセンター中央病院 血液内科
-
Uike Naokuni
Department Of Hematology National Kyushu Cancer Center
-
Uike Naokuni
Department Of Hematology National Kyushu Cancer Center Hospital
-
Uike N
National Kyusyu Cancer Center
-
Terui Shoji
Diagnostic Radiology Division National Cancer Center Hospital
-
Itoh K
Division Of Oncology And Hematology National Cancer Center Hospital East
-
Itoh Kuniaki
神戸大学 医学研究科腫瘍内科学
-
Igarashi T
Division Of Oncology And Hematology National Cancer Center Hospital East
-
Igarashi Tadahiko
神戸大学 医学研究科腫瘍内科学
-
Igarashi Tadahiko
国立がんセンター東病院
-
Kagami Yoshitoyo
名古屋大学医学部附属病院 病理部
-
HAYASHI Masaki
Department of Clinical Development, Bayer Health Care
-
Uoshima Nobuhiko
京都府立医科大学 血液･腫瘍内科学
-
Uoshima Nobuhiko
Matsushita Memorial Hospital Moriguchi Jpn
-
Uoshima Nobuhiko
1st Department Of Internal Medicine Kyoto Prefectureal University Of Medicine
-
Usui Noriko
東京慈恵会医科大学附属病院 中央検査部
-
Usui N
Division Of Hematology And Oncology Department Of Medicine Jikei University
-
Usui Noriko
Jikei University Hospital
-
Ichimura Koichi
Department Of Hematology And Rheumatology Tohoku University Graduate School Of Medicine
-
Ishizawa Kenichi
東北大学 血液･免疫病学分野
-
Ishizawa Kenichi
国立がんセンター東病院
-
WATANABE Toru
National Cancer Center Hospital
-
Yamamoto Kazuhito
Department Of Hematology And Cell Therapy Aichi Cancer Center Hospital
-
Kajiguchi Tomohiro
Department Of Hematology Nagoya University Graduate School Of Medicine
-
Kanakura Yuzuru
大阪大学 医学系研究科心臓血管外科
-
Usui N
Jikei University Hospital
-
Kawase Yoshiaki
Department Of Internal Medicine Japanese Red Cross Nagoya First Hospital
-
Kuroishi Tetsuo
愛知県がんセンター研究所
-
Takeuchi Takahiro
Cancer Screening Division Research Center For Cancer Prevention And Screening National Cancer Center
-
Takahashi Toshitada
愛知県がんセンター研究所 腫瘍免疫学
-
Itoh Kuniaki
Division Of Oncology And Hematology National Cancer Center Hospital East
-
Itoh Kuniaki
Hematology And Oncology Division National Cancer Center Hospital East
-
Itoh Kuniaki
Department Of Chemistry Faculty Of Science Kobe University
-
Nakamura Shigeo
Department Of Pathology Nagoya University Graduate School Of Medicine
-
Uike Naokuni
Department Of Hemato-oncology Kyushu Cancer Center
-
Kuroishi Tetsuo
Division Of Epidemiology And Prevention Aichi Cancer Center Research Institute Aichi Cancer Center H
-
Tobinai Kensei
Hematology Division National Cancer Center Hospital
-
Tobinai Kensei
Hematology And Stem Cell Transplantation Division National Cancer Center Hospital
-
Kobayashi Yukio
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
Nakata Masanobu
Division Of Oncology And Hematology National Cancer Center Hospital East
-
Usui Noriko
Jikei Univ. Hospital Tokyo Jpn
-
Usui Noriko
The "lung Injury By Bortezomib" Joint Committee Of The Japanese Society Of Hematology And
-
Kobayashi Masayuki
Hematology Division National Cancer Center Hospital
-
Takatsuki K
Kumamoto Univ. School Of Medicine Kumamoto Jpn
-
Ikegame K
Division Of Hematology Department Of Internal Medicine Hyogo College Of Medicine
-
Ikegame Kazuhiro
Division Of Hematology Department Of Internal Medicine Hyogo College Of Medicine
-
Watanabe T
Tokyo Univ. Tokyo
-
Tobinai Kensei
National Cancer Center Hospital
-
Tobinai Kensei
Department Of Pharmacotherapy National Cancer Institute
-
Takenaka T
National Cancer Center Hospital Tokyo Jpn
-
Ichimura Koichi
Department Of Pathology Okayama University Graduate School Of Medicine And Dentistry
-
Igarashi Tadahiko
Hematology And Oncology Division National Cancer Center Hospital East
-
Terauchi Takashi
Diagnostic Radiology Divisions National Cancer Center Hospital
-
Ichimura Koichi
Department Of Pathology And Molecular Diagnostics Aichi Cancer Center
-
Kagami Yoshitoyo
Department Of Pathology School Of Medicine Kurume University
-
Ichimura Kouichi
Department Of Pathology Okayama University Medical School And Graduate School Of Medicine Dentistry
-
Watanabe T
Department Of Pathology Gifu University School Of Medicine
-
Takeyama K
National Cancer Center Hospital Tokyo Jpn
-
Tanimoto K
Hematology And Stem Cell Transplantation Division National Cancer Center Hospital
-
Usui Noriko
Division Of Oncology & Hematology Department Of Internal Medicine The Jikei University School Of
-
Yano Kunio
県西部浜松医療センター
-
Narabayashi Masaru
Division Of Oncology And Hematology National Cancer Center Hospital East
-
Watanabe Toru
Hematology And Stem Cell Transplantation Division National Cancer Center Hospital
-
Hayashi Masaki
Department Of Clinical Development Bayer Health Care
-
Tanimoto Kazuki
Hematology And Stem Cell Transplantation Division National Cancer Center Hospital
-
Takahashi Isao
Second Department Of Internal Medicine Okayama University Medical School
-
Endo Keigo
Nuclear Medicine Gunma University Graduate School Of Medicine
-
Endo Keigo
Department of Diagnostic Radiology and Nuclear Medicine, Gunma University Graduate School of Medicine
関連論文
- Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Japan : a retrospective analysis of 1,057 cases from Kyushu Lymphoma Study Group
- Accumulation of common polymorphisms is associated with development of hypertension : a 12-year follow-up from the Ohasama study
- Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy
- Progressive multifocal leukoencephalopathy in a patient with B-cell lymphoma during rituximab-containing chemotherapy : case report and review of the literature
- Stromal cells in bone marrow play important roles in pro-inflammatory cytokine secretion causing fever following bortezomib administration in patients with multiple myeloma
- Diffuse large B-cell lymphoma after transformation from low-grade follicular lymphoma : morphological, immunohistochemical, and FISH analyses
- Nocardia exalbida brain abscess in a patient with follicular lymphoma
- Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma
- Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy
- Promoter Hypermethylation of the DNA-Repair Gene O^6-Methylguanine-DNA Methyltransferase and p53 Mutation in Diffuse Large B-Cell Lymphoma
- Loss of O^6-Methylguanine-DNA Methyltransferase Protein Expression Is a Favorable Prognostic Marker in Diffuse Large B-Cell Lymphoma
- Quantification of molecules in ^1H-NMR metabolomics with formate as a concentration standard
- Standardized Prevalence Ratios for Chronic Hepatitis C Virus Infection Among Adult Japanese Hemodialysis Patients
- In vivo Retrovirus-mediated Herpes Simplex Virus Thymidine Kinase Gene Therapy Approach for Adult T Cell Leukemia in a Rat Model
- Serum Levels of Soluble Fas/APO-1 Receptor in Human Retroviral Infection and Associated Diseases
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- Dietary Risk Factors for Colon and Rectal Cancers : A Comparative Case-Control Study
- Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
- Plasma B-Type Natriuretic Peptide Level and Cardiovascular Events in Chronic Kidney Disease in a Community-Based Population
- Factors Influencing Participation Rate in a Baseline Survey of a Genetic Cohort in Japan
- Epstein-Barr virus involvement is a predictive factor for the resistance to chemoradiotherapy of gastric diffuse large B-cell lymphoma
- Phase I study of radioimmunotherapy with an anti-CD20 murine radioimmunoconjugate (^Y-ibritumomab tiuxetan) in relapsed or refractory indolent B-cell lymphoma
- Durable Response but Prolonged Cytopenia after Cladribine Treatment in Relapsed Patients with Indolent non-Hodgkin's Lymphomas : Results of a Japanese Phase II Study
- t(11 ; 18)-Bearing Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma Responding to Cladribine
- Two Entities of Precursor T-Cell Lymphoblastic Leukemia/Lymphoma Based on Radiologic and Immunophenotypic Findings
- Primary Mediastinal Large B-Cell Lymphoma : A Single-Institution Clinical Study in Japan
- EBV-Positive Burkitt Lymphoma as a Late-Onset Posttransplantion Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation
- Primary Hepatic Low-Grade B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue Type : A Case Report and Review of the Literature
- Successful Allogeneic Bone Marrow Transplantation in a Case of Adult Precursor B-Lymphoblastic Lymphoma
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Unrelated-Donor Bone Marrow Transplantation with a Conditioning Regimen Including Fludarabine, Busulfan, and 4 Gy Total Body Irradiation
- Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Evaluation of organ involvement in intravascular large B-cell lymphoma by ^F-fluorodeoxyglucose positron emission tomography
- Sustained Remission after Rituximab-containing Chemotherapy for Intravascular Large B-cell Lymphoma
- Epigenetic Regulation of CD20 Protein Expression in a Novel B-Cell Lymphoma Cell Line, RRBL1, Established from a Patient Treated Repeatedly with Rituximab-Containing Chemotherapy
- Phase III study to evaluate the use of high-dose chemotherapy as consolidation of treatment for high-risk postoperative breast cancer : Japan Clinical Oncology Group study, JCOG 9208
- Phase II Study of Cladribine(2-Chlorodeoxyadenosine) in Relapsed or Refractory Adult T-Cell Leukemia-Lymphoma
- Imatinib Provides Durable Molecular and Cytogenetic Responses in a Practical Setting for Both Newly Diagnosed and Previously Treated Chronic Myelogenous Leukemia : A Study in Nagasaki Prefecture, Japan
- Primary Hepatic Follicular Lymphoma : A Case Report and Discussion of Chemotherapy and Favorable Outcomes
- Randomized phase II study of concurrent and sequential rituximab and CHOP chemotherapy in untreated indolent B-cell lymphoma
- Central nervous system involvement in intravascular large B-cell lymphoma : A retrospective analysis of 109 patients
- Morphological spectrum of cyclin D1-positive mantle cell lymphoma : Study of 168 cases
- Systemic Mastocytosis with Extensive Polypoid Lesions in the Intestines; Successful Treatment with Interferon-α
- Iron Intake and Associated Factors in General Japanese Population : NIPPON DATA80, NIPPON DATA90 and National Nutrition Monitoring
- Extragonadal germ cell tumors in Japan
- 1P345 NMRメタボロミクスの医療への応用 : 透析患者血漿と廃液の解析(その他,第48回日本生物物理学会年会)
- CHANGES IN ACTIVITIES OF DAILY LIVING,PHYSICAL FITNESS, AND DEPRESSIVE SYMPTOMS AFTER SIX-MONTH PERIODIC WELL-ROUNDED EXERCISE PROGRAMS FOR OLDER ADULTS LIVING IN NURSING HOMES OR SPECIAL NURSING FACILITIES
- B-cell lymphoma accompanying monoclonal macroglobulinemia with features suggesting marginal zone B-cell lymphoma
- Association between vitamin D and calcium intake and breast cancer risk according to menopausal status and receptor status in Japan
- Heavy smoking history interacts with chemoradiotherapy for esophageal cancer prognosis : A retrospective study
- Interaction of the Effects of Alcohol Drinking and Polymorphisms in Alcohol-Metabolizing Enzymes on the Risk of Female Breast Cancer in Japan
- Adhesion-dependent growth of primary adult T cell leukemia cells with down-regulation of HTLV-I p40Tax protein : a novel in vitro model of the growth of acute ATL cells
- Broken Sperm, Cytoplasmic Droplets and Reduced Sperm Motility Are Principal Markers of Decreased Sperm Quality Due to Organophosphorus Pesticides in Rats
- Phase II study of chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia or lymphoblastic lymphoma : Japan Clinical Oncology Group study 9004
- A Phase II Study of VEPA/FEPP Chemotherapy for Aggressive Lymphoma in Elderly Patients : Japan Clinical Oncology Group Study JCOG9203
- Deoxycoformycin-Containing Combination Chemotherapy for Adult T-Cell Leukemia-Lymphoma : Japan Clinical Oncology Group Study (JCOG9109)
- Leukemic infiltration of the lung following allogeneic hematopoietic stem cell transplantation
- Adult T-Cell Leukemia-Lymphoma Successfully Treated with 2-Chlorodeoxyadenosine
- A Novel Plasmacytoid Dendritic Cell Line, CAL-1, Established from a Patient with Blastic Natural Killer Cell Lymphoma
- Re-Treatment of Relapsed Indolent B-Cell Lymphoma With Rituximab
- Induction of antitimor cytotoxic activity using CD34^+ cord blood cell-derived and irradiated tumor cell-primed dendritic cells
- Effects of interleukin-11 on carboplatin-induced thrombocytopenia in rats and in combination with stem cell factor
- Phase I/II study of tandem high-dose chemotherapy with autologous peripheral blood stem cell transplantation for advanced multiple myeloma
- Clinical features of adult acute leukemia with 11q23 abnormalities in Japan : a co-operative multicenter study
- Safe switching from dasatinib to nilotinib after a 1-month off-drug period for persistent pleural effusion in patients with chronic myelogenous leukemia in chronic phase
- A high risk of life-threatening infectious complications in mycophenolate mofetil treatment for acute or chronic graft-versus-host disease
- Aggressive CD5-positive diffuse large B cell lymphoma showing c-myc rearrangements developed in a patient with autoimmune hemolytic anemia
- Pitavastatin, an HMG-CoA Reductase Inhibitor, Ameliorates Endothelial Function in Chronic Smokers
- Effects of a 12-Month Multicomponent Exercise Program on Physical Performance, Daily Physical Activity, and Quality of Life in Very Elderly People With Minor Disabilities : An Intervention Study
- Granulocyte Colony-Stimulating Factor-Primed Donor Lymphocyte Infusion after Salvage Chemotherapy for Treatment of Relapsed Acute Leukemia after Allogeneic Stem Cell Transplantation
- Hematopoietic stem cell transplantation for therapy-related myelodysplastic syndrome and acute leukemia : a single-center analysis of 47 patients
- Age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorders : Special references to lymphomas surrounding this newly recognized clinicopathologic disease
- Rationale, Design, and Profiles of the New Integrated Suburban Seniority Investigation (NISSIN) Project : A Study of an Age-Specific, Community-Based Cohort of Japanese Elderly
- TEL/AML1 fusion gene resulting from a cryptic t(12;21) is uncommon in adult patients with B-cell lineage ALL and CML lymphoblastic transformation
- A Human T-Cell Lymphotropic Virus Type-I Carrier with Chronic Renal Failure, Aplastic Anemia, Myelopathy, Uveitis, Sjogren's Syndrome and Panniculitis
- Paroxysmal Nocturnal Hemoglobinuria
- Markedly high plasma erythropoietin and granulocyte-colony stimulating factor levels in patients with paroxysmal nocturnal hemoglobinuria
- Cyclosporin-responsive pancytopenia and HLA class II alleles of a patient with paroxysmal nocturnal hemoglobinuria
- T-lymphoblastic lymphoma/leukemia cells nagative for CD52 and CD59
- Migration to an inflammatory site in vivo of paroxysmal nocturnal hemoglobinuria lymphocytes
- Induction of the C/EBPβ Gene by Dexamethasone and Glucagon in Primary-Cultured Rat Hepatocytes^1
- Serum amino acid disturbance in multiple myeloma with hyperammonemia
- Hyperdiploid myeloma cell as an indicator of poor prognosis and drug refractoriness
- Potential efficacy of the oral histone deacetylase inhibitor vorinostat in a phase I trial in follicular and mantle cell lymphoma
- Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma
- Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab
- Treatment of Indolent Non-Hodgkin's Lymphoma with Cladribine as Single-Agent Therapy and in Combination with Mitoxantrone
- Proteasome inhibitor, bortezomib, for myeloma and lymphoma
- Detection of Two Cell Populations Corresponding to Distinct Maturation Stages in API-2/MLT-Positive Mucosa-Associated Lymphoid Tissue Lymphoma Cells Proliferating in Pleural Effusion
- Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma
- Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with
- Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
- Randomized phase II study of concurrent and sequential combinations of rituximab plus CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) chemotherapy in untreated indolent B-cell non-Hodgkin lymphoma : 7-year follow-up results
- Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Phase I and pharmacokinetic study of bendamustine hydrochloride in relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Phase I study of inotuzumab ozogamicin (CMC-544) in Japanese patients with follicular lymphoma pretreated with rituximab-based therapy
- Phase I study of LY2469298, an Fc-engineered humanized anti-CD20 antibody, in patients with relapsed or refractory follicular lymphoma
- Delayed treatment with vitamin C and N-acetyl-L-cysteine protects Schwann cells without compromising the anti-myeloma activity of bortezomib
- Feasibility and pharmacokinetic study of bendamustine hydrochloride in combination with rituximab in relapsed or refractory aggressive B cell non-Hodgkin's lymphoma